Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 3/20 | 1.00 |
| ▸ | DRD3 | P35462 | 2/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.59 |
| ▸ | HTR3E | A5X5Y0 | 3/20 | 0.59 |
| ▸ | HTR3B | O95264 | 3/20 | 0.59 |
| ▸ | HTR3A | P46098 | 3/20 | 0.59 |
| ▸ | HTR3D | Q70Z44 | 3/20 | 0.59 |
| ▸ | HTR3C | Q8WXA8 | 3/20 | 0.59 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.59 |
| ▸ | HTR1A | P08908 | 3/20 | 0.59 |
| ▸ | HTR7 | P34969 | 3/20 | 0.59 |
| ▸ | HTR2C | P28335 | 3/20 | 0.59 |
| ▸ | THRB | P10828 | 2/20 | 0.59 |
| ▸ | HTR6 | P50406 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | HTR2A | P28223 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30855584 | 1.00 | DRD2 (1.00) | DRD2DRD3ADRB1HTR3EHTR3B | |
| Hydrochloric Acid SCHEMBL6494513 | 0.98 | DRD2 (0.97) | DRD2DRD3ADRB1HTR3EHTR3B | |
| Hydrochloric Acid SCHEMBL6408589 | 0.98 | DRD2 (0.97) | DRD2DRD3ADRB1HTR3EHTR3B | |
| Hydrochloric Acid SCHEMBL29882147 | 0.98 | DRD2 (0.97) | DRD2DRD3ADRB1HTR3EHTR3B | |
| SCHEMBL20159295 | 0.94 | DRD2 (0.88) | DRD2DRD3ADRB1HTR3EHTR3B | |
| Hydrochloric Acid SCHEMBL20141804 | 0.92 | DRD2 (0.85) | DRD2DRD3ADRB1HTR3EHTR3B | |
| SCHEMBL8709443 | 0.92 | DRD2 (0.85) | DRD2DRD3ADRB1HTR3EHTR3B | |
| SCHEMBL15800697 | 0.89 | DRD2 (0.79) | DRD2DRD3HTR1ATP53NOTUM | |
| Trifluoroacetic Acid SCHEMBL3847590 | 0.86 | DRD2 (0.74) | DRD2DRD3ADRB1HTR3EHTR3B | |
| SCHEMBL3537217 | 0.85 | DRD2 (0.74) | DRD2DRD3HTR1AALDH1A1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118221620-A | Benzamide phenylpiperazine radioactive compound and preparation method and application thereof | 中国科学院高能物理研究所 | 2024-06-21 | — | — | CN | claimed |
| EP-3728234-B1 | RADIOLABELED COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2025-05-14 | — | — | EP | disclosed |
| CN-118745132-A | Cedrus alcohol derivative and preparation method and application thereof | 沈阳药科大学 | 2024-10-08 | — | — | CN | disclosed |
| CN-118221620-A | Benzamide phenylpiperazine radioactive compound and preparation method and application thereof | 中国科学院高能物理研究所 | 2024-06-21 | — | — | CN | disclosed |
| CN-111196806-B | Guanidine derivative and application thereof | 广东东阳光药业股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117751099-A | Amide compound and application thereof | 中国药科大学 | 2024-03-22 | — | — | CN | disclosed |
| US-11718588-B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | GALAPAGOS NV (BE) | 2023-08-08 | — | — | US | disclosed |
| US-11718588-B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | GALAPAGOS NV (BE) | 2023-08-08 | — | — | US | disclosed |
| US-11718588-B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | GALAPAGOS NV (BE) | 2023-08-08 | — | — | US | disclosed |
| WO-2023011596-A1 | AMIDE COMPOUND AND USE THEREOF | 中国药科大学 | 2023-02-09 | — | — | WO | disclosed |
| WO-2002068399-A1 | ARYL CARBAMATE DERIVATIVES, PREPARATION AND USE THEREOF | CEREP (FR) | 2002-09-06 | — | — | WO | disclosed |
| US-20020045613-A1 | 1-aroyl-piperidinyl benzamidines | AVENTIS PHARMACEUTICALS PRODUCTS INC. | 2002-04-18 | — | — | US | disclosed |
| US-6355642-B1 | PSYCHOLOGICAL DISORDERS AND BRAIN DISORDERS | MEIJI SEIKA KAISHA, LTD. (JP) | 2002-03-12 | — | — | US | disclosed |
| WO-2001081310-A1 | 1-AROYL-PIPERIDINYL BENZAMIDINES | AVENTIS PHARMACEUTICALS INC. (US) | 2001-11-01 | — | — | WO | disclosed |
| CN-1071754-C | Pyrimidinylpyrazole derivative | DAIICHI SEIYAKU CO (JP) | 2001-09-26 | — | — | CN | disclosed |
| EP-0937715-A1 | TETRAHYDROBENZINDOLE COMPOUNDS | MEIJI SEIKA KAISHA LTD. (JP) | 1999-08-25 | — | — | EP | disclosed |
| WO-1999031096-A1 | PIPERAZINE DERIVATIVES USEFUL AS HYPOGLYCEMIC AGENTS | SHAMAN PHARMACEUTICALS, INC. (US) | 1999-06-24 | — | — | WO | disclosed |
| US-5852019-A | Pyrimidinylpyrazole derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1998-12-22 | — | — | US | disclosed |
| CN-1166833-A | pyrimidinyl pyrazole derivatives | DAIICHI SEIYAKU CO (JP) | 1997-12-03 | — | — | CN | disclosed |
| EP-0784055-A1 | PYRIMIDINYLPYRAZOLE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1997-07-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020045613-A1 | 1-aroyl-piperidinyl benzamidines | TPSAB1, TPSB2, CMA1 | DRD2 2633/4885DRD3 2646/4885ADRB1 898/4885 |
| US-11718588-B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | ADAMTS1, ADAMTS5, ADAMTS7 | DRD2 4712/4885DRD3 4551/4885ADRB1 3478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.